SWA
VRTX icon

Sutton Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Sutton Wealth Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$32.7K Buy
94
+15
+19% +$5.25K 0.02% 283
2023
Q2 		$27.8K Hold
79
– – 0.01% 304
2023
Q1 		$24.9K Sell
79
-7
-8% -$2.1K 0.01% 281
2022
Q4 		$24.8K Hold
86
– – 0.01% 608
2022
Q3 		$24.9K Sell
86
-1
-1% -$288 0.01% 592
2022
Q2 		$24.5K Hold
87
– – 0.01% 598
2022
Q1 		$22.7K Buy
87
+7
+9% +$1.66K 0.01% 670
2021
Q4 		$17.6K Buy
80
+29
+57% +$5.64K 0.01% 748
2021
Q3 		$9.25K Sell
51
-12
-19% -$2.34K ﹤0.01% 939
2021
Q2 		$12.7K Buy
63
+5
+9% +$1.05K ﹤0.01% 831
2021
Q1 		$12.5K Sell
58
-10
-15% -$2.2K ﹤0.01% 810
2020
Q4 		$16.1K Buy
68
+7
+11% +$1.61K 0.01% 672
2020
Q3 		$16.6K Hold
61
– – 0.01% 596
2020
Q2 		$17.7K Buy
61
+3
+5% +$813 0.01% 572
2020
Q1 		$13.8K Buy
58
+9
+18% +$2.06K 0.01% 570
2019
Q4 		$10.7K Hold
49
– – 0.01% 801
2019
Q3 		$8.3K Hold
49
– – ﹤0.01% 842
2019
Q2 		$8.99K Buy
49
+2
+4% +$350 0.01% 801
2019
Q1 		$8.65K Buy
47
+5
+12% +$924 0.01% 819
2018
Q4 		$6.96K Hold
42
– – ﹤0.01% 825
2018
Q3 		$8.1K Hold
42
– – 0.01% 825
2018
Q2 		$7.14K Sell
42
-113
-73% -$17.5K 0.01% 882
2018
Q1 		$25.3K Hold
155
– – 0.02% 478
2017
Q4 		$23.2K Buy
155
+117
+308% +$17.3K 0.02% 503
2017
Q3 		$5.78K Hold
38
– – ﹤0.01% 856
2017
Q2 		$4.9K Buy
38
+13
+52% +$1.56K ﹤0.01% 877
2017
Q1 		$2.73K Sell
25
-6
-19% -$528 ﹤0.01% 914
2016
Q4 		$2.28K Sell
31
-294
-90% -$23.9K ﹤0.01% 920
2016
Q3 		$28.3K Buy
325
+15
+5% +$1.42K 0.03% 370
2016
Q2 		$26.7K Hold
310
– – 0.03% 370
2016
Q1 		$24.6K Buy
+310
New +$28K 0.02% 385

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sutton Wealth Advisors's VRTX Position: Q3 2023 in Review

Sutton Wealth Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 19% in Q3 2023, buying an estimated $5.25K and bringing the position to 94 shares worth $32.7K. The position accounts for 0.02% of the portfolio, ranked #283.

Sutton Wealth Advisors first reported a position in VRTX in Q1 2016 and has held it in 31 quarters since. 1,278 funds tracked by Wall St. Rank hold VRTX as of Q3 2023.

  • Sutton Wealth Advisors held 94 shares of Vertex Pharmaceuticals worth $32.7K as of Q3 2023.
  • Sutton Wealth Advisors bought 15 Vertex Pharmaceuticals shares in Q3 2023, an estimated $5.25K.
  • Vertex Pharmaceuticals made up 0.02% of Sutton Wealth Advisors's portfolio in Q3 2023, its #283 holding.
  • Sutton Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q1 2016 and has held it in 31 quarters since.
  • 1,278 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2023.

Based on Sutton Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.